From: Quercetin with the potential effect onĀ allergic diseases
Diseases | Dosage | Cell/cell line | Animal | Quercetinās effect | References |
---|---|---|---|---|---|
Allergic asthma | 10ā6ā3āĆā10ā4 M | Tracheal tissue | Male Wistar rat | Inhibits rat tracheal contractility | [24] |
40Ā ĀµM | NCI-H292 cells | n/a | Inhibit MUC5AC gene expression | [25] | |
40Ā ĀµM | HBE16 | n/a | Inhibit HNE-induced MUC5AC expression in human airway epithelial cells through PKC/EGFR/ERK signal transduction pathway | [26] | |
Allergic rhinitis | 4.0Ā Ī¼M | HNEpC | n/a | Suppressed the ability of cells to produce RANTES and eotaxin | [38] |
1.0Ā nM | HNEpC | Ā | Modified the clinical condition of AR through the suppression of NO production from nasal epithelial cells after IL-4 stimulation | [41] | |
Atopic dermatitis | 30Ā Ī¼M | RBL-2H3 | Wistar rat and BALB/c | Upregulation of HO after short exposure Induction of HO-1 expression after long exposure | [51] |
5 mg/ml | Keratinocyte | n/a | Strong ability to scavenge free radicals and protect human keratinocytes against hydrogen peroxide damage | [52] |